A single-dose study of IBIO-600 in healthy overweight or obese adults
Part of Hormones & metabolism clinical trials.
This trial tests a single dose of an experimental treatment called IBIO-600 to see if it's safe and how it works in overweight or obese adults. It's for people who are generally healthy and have a stable weight, without diabetes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age 18 to 65 and in good general health.
- Your body mass index (BMI) must be between 27.0 and 34.9 — that's considered overweight or mildly obese.
- Your weight must have stayed about the same (no more than 5% change) in the last 3 months.
- You cannot have diabetes (type 1 or 2).
- You must be a non-smoker and have not used nicotine products (like cigarettes or vaping) for at least 1 month before starting.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an experimental injection called UBT37034 to see if it is safe and how the body handles it. It is for people who are overweight but otherwise healthy. By joining, you could help find new ways to help with weight control—and you'll receive close monitoring and care.
This study tests a new medication called IBI3046 for people who are overweight or have obesity. The purpose is to see if it helps with weight loss and works safely.
This study tests an experimental drug called IBI3042 in healthy people who are normal weight, overweight, or obese. It is an early-stage trial looking at how safe and tolerable the drug is, and how it affects the body, which could eventually lead to a treatment for weight loss.
This study tests an investigational drug called IBI3040 in healthy adults and in adults who are overweight or obese. It aims to see how the drug affects the body, which may help with weight management. Participants will be monitored closely throughout the study.
This study tests a new drug called BI 3034701 to see how well people tolerate different doses. It may help with weight loss and related health issues.
This study tests a new experimental medicine called IBI3042, given as a single dose, to see how safe it is in healthy volunteers. It is an early-phase trial that helps doctors understand if the drug is well-tolerated before testing it in patients.
Hear when a new Overweight , Obesity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.